CASI Pharmaceuticals (CASIF) Non-cash Items (2023 - 2025)

CASI Pharmaceuticals has reported Non-cash Items for 3 years, with the latest figure at $2.1 million in Q4 2025.

• For the quarter ending Q4 2025, Non-cash Items rose 53.68% year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $2.1 million (up 53.68% YoY), and the FY2025 full-year result was $2.1 million, up 53.68% from the prior year.
• Non-cash Items for Q4 2025 stood at $2.1 million, up from $1.4 million in the prior quarter.
• The five-year high for Non-cash Items was $2.2 million in Q4 2023, with the low at $1.4 million in Q4 2024.
• Historically, Non-cash Items has averaged $1.9 million across 3 years, with a median of $2.1 million in 2025.
• Annual changes were most pronounced in 2024 — Non-cash Items plunged 38.35% — and 2025, when it jumped 53.68%.
• CASI Pharmaceuticals' Non-cash Items stood at $2.2 million in 2023, then sank by 38.35% to $1.4 million in 2024, then surged by 53.68% to $2.1 million in 2025.
• The last three Non-cash Items figures came in at $2.1 million (Q4 2025), $1.4 million (Q4 2024), and $2.2 million (Q4 2023), per Business Quant data.